Skip to main content

JPMORGAN CHASE & CO

Position in KROS — Keros Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in KROS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$156,476
-$259,509 QoQ
Shares Held
14,624
-61.2% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 48% Shared 0% None 52%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. KROS ranks #249 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $156,476 14,624
2026-03-31 $415,985 37,680
2025-12-31 $379,468 18,638
2025-09-30 $2,720,105 171,941
2025-06-30 $636,179 47,654
2025-03-31 $26,498,654 2,600,457
2025-03-31 $26,363,017 2,587,146
2024-12-31 $3,378,610 213,431
2024-09-30 $1,806,963 31,117
2024-06-30 $1,402,760 30,695
2024-03-31 $3,668,140 55,410
2023-12-31 $2,490,724 62,644
2023-09-30 $1,691,838 53,069
2023-06-30 $1,192,943 29,690
2023-03-31 $1,000,034 23,420
2022-12-31 $1,991,916 41,481
2022-09-30 $668,543 17,771
2022-06-30 $420,637 15,224
2022-03-31 $2,040,770 37,528
2021-12-31 $1,942,471 33,199
2021-09-30 $415,457 10,502
2021-06-30 $393,738 9,271
2021-03-31 $393,242 6,389
2020-12-31 $411,529 5,834
2020-09-30 $100,166 2,597
2020-06-30 $87,885 2,343